Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Specialty Medicine Compounding Pharmacy, P.C.
483
•Specialty Medicine Compounding Pharmacy, P.C.•November 5, 2013

Specialty Medicine Compounding Pharmacy, P.C. – FDA 483, Nov 5, 2013

Record Details

The FDA Form 483 details numerous deficiencies at a facility producing sterile injectable drug products, including Dextrose 50% and Methylcobalamin UDP PF 25mg/mL.

Key violations include: * **Aseptic Processing:** Procedures to prevent microbiological contamination are not established or followed. Process simulations (media fills) are inadequate, not reflecting worst-case conditions. Manual aseptic operations, such as filling 25 open vials in an ISO 5 hood and multi-day bulk solution transfers, pose contamination risks. * **Environmental & Personnel Monitoring:** The program is deficient, lacking routine personnel monitoring (every shift/multiple locations), passive/active viable air monitoring during production, and adequate surface monitoring frequency. Non-viable particulate monitoring is not performed routinely. * **Facility Controls:** Air pattern analyses (smoke studies) for ISO 5 hoods are not performed under dynamic conditions, and no video is maintained. Air pattern analysis for the ISO 7 buffer room is absent. HEPA filter integrity testing for ISO 7 cleanroom filters (installed 11/01/2013) has not been performed. Pressure differentials between ISO 5 hoods and the ISO 7 cleanroom are not continuously monitored. * **Gowning & Materials:** Gowning components (hair covers, masks, Tyvek suit) are not sterile, leaving exposed skin. Storage conditions and clean hold times for sterilized containers, closures, and

Company
Specialty Medicine Compounding Pharmacy, P.C.
Inspection date
November 5, 2013
Product type
Drugs
Office
Detroit District Office
Person
  • Jeffrey D. Meng (Associate Director)
View Company Profile

ID · b96c486b-4466-4798-9710-6fa3513ec063

Violation Codes1
FD&C Act 801(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Specialty Medicine Compounding Pharmacy, P.C.
  • WARNING_LETTER - 2013-11-05November 5, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Specialty Medicine Compounding Pharmacy, P.C.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.